Does your solution identify diverters?

Or does it fall on you to find them?

Visit Booth 3 at the 2023 IHFDA Annual Conference to find a better way

Most facilities have a solution that will claim to monitor transactions and find discrepancies – but can they also claim to identify diverters?

Visit Booth 3 to learn how MAAP Analytics can help find the needle in the haystack and go:

• Beyond Discrepancies using machine learning and predictive analyses instead of just reports
• Beyond Transactions with an emphasis on robust data integrity
• Beyond Doubt with nearly 100% accuracy based on years of studies at top facilities in the country

What:

2023 IHFDA Annual Conference

Who:

ANiGENT Staff

When:

September 18-20, 8 AM to 5 PM CT Daily

Where:

Booth 3

Chicago Westin O'Hare (Rosemont, IL)

How:

Attend the conference in-person or virtually

Request a Demo

Unable to attend? Click the button below to schedule a demo and see how MAAP Analytics can go beyond discrepancies, beyond transactions, and beyond doubt to identify diverters.

About ANiGENT



ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements.

To Request a Demo: info@anigent.com

833-264-4368

© ANiGENT LLC | All Rights Reserved | Privacy Policy

Follow RXinsider on Social Media